Explore Log in Sign up

Explore

@cancers-mdpi.bsky.social Sep 17, 2026, 10:11 AM

🎯Editor's Choice Paper
#Immunotherapeutic Strategies for #ProstateCancer: A Comprehensive Review
✍️Ana K. Flores-Islas, Cecilia Rico-Fuentes et al.
Find out more🖇️ www.mdpi.com/2072-6694/18...
#PCa #ICIs #mCRPC

Figure 1. PCa tumor immune microenvironment (TIME). An immunosuppressive environment and Immunological ignorance characterize TIME in PCa tumors; some of the most relevant immune cells are effector Treg cells (eTreg), CD8+ T cells, M2 tumor-associated macrophages (TAMs), CD4+ T-cells, and myeloid-derived suppressor cells (MDSCs). Tumor-associated antigens and tumor-specific antigens can be used as diagnostic, prognostic/treatment, or research tools in PCa. PSA: Prostate-specific antigen; PSMA: Prostate-specific membrane antigen; PAP: Prostate acid phosphatase; PSCA: Prostate stem cell antigen; STEAP: Six-transmembrane epithelial antigens of the prostate; PCA3: Prostate cancer antigen 3.

Terms of Use Privacy Policy Community Standards Help Get the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-11 02:37:10 EDT